Coronaropathies Prévention cardio-vasculaire
JESFC 2024

Autour de la cardiopathie ischémique

Publié le vendredi 19 janvier 2024

Modérateur(s) :

Grégory Ducrocq , Sandra Zendjebil

Orateur(s) :

Farouk Boukerche , Mojgan Laali , Quang Pham , Iyad Abou Saleh , Kévin Boussion , Leila Bezdah , Arnaud Ekou , Manveer Singh , Amine Mamoun Boutaleb

Dans la session

Arnaud Ekou Thirty-day and one-year outcomes and predictors of mortality following acute myocardial infarction in Côte d‘Ivoire : data from the REACTIV survey
Manveer Singh Factors associated with coronary revascularization in patients with suspected NSTE-ACS from a large multicenter prospective registry
Arnaud Ekou Type 1 and type 2 myocardial infarction in a sub-Saharan Africa population: data from the REACTIV survey
Amine Mamoun Boutaleb Hyperhemic and non hyperhemic pressure ratio for the evaluation of coronary artery disease functional severity
Farouk Boukerche Long-term outcome and characteristics of patients with NSTEMI and non-obstructive coronary arteries
Mojgan Laali Impact of transit-time flow measurement in patients undergoing on-pump coronary artery surgery
Quang Pham Performance of intracoronary and intravenous ergonovine for diagnostic of vasospastic angina: a retrospective analysis using propensity matching
Kévin Boussion Is female sex a risk factor for mortality after coronary artery revascularization surgery in France?
Leila Bezdah Delays in management of ST-segment elevation myocardial infarction
Farouk Boukerche Mechanisms, influencing factors, and management of drug eluting stent coronary restenosis

Partager l'article :